Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Miles

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2019
HER2-Overexpressing/Amplified Breast Cancer as a Testing Ground for Antibody-Drug Conjugate Drug Development in Solid TumorsMark D Pegram, David Miles, C Kimberly Tsui, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2012
Combining capecitabine and bevacizumab in metastatic breast cancer: a comprehensive reviewDavid Miles, Christoph Zielinski, Miguel Martin, et al.
European Journal of Cancer (Oxford, England : 1990)|November 28, 2017
Overall survival in MERiDiAN, a double-blind placebo-controlled randomised phase III trial evaluating first-line bevacizumab plus paclitaxel for HER2-negative metastatic breast cancerDavid Miles, David Cameron, Magalie Hilton, et al.
Physical Review. E|June 17, 2023
Self-diffusion of a relativistic Lennard-Jones gas via semirelativistic molecular dynamicsDavid Miles Testa, Pontus Svensson, Jacob Jackson, et al.
Biomolecules|September 28, 2024
Advancements in Green Nanoparticle Technology: Focusing on the Treatment of Clinical PhytopathogensSunny Mukherjee, Anamika Verma, Lingxue Kong, et al.
Functional & Integrative Genomics|February 23, 2013
Transcriptional profiling of Zea mays roots reveals roles for jasmonic acid and terpenoids in resistance against Phytophthora cinnamomiJane Alisa Allardyce, James Edward Rookes, Hashmath Inayath Hussain, et al.
Targeted Oncology|January 23, 2017
Splenic Enlargement and Bone Marrow Hyperplasia in Patients Receiving Trastuzumab-Emtansine for Metastatic Breast CancerMichael Kosmin, Andreas Makris, Noorulhuda Jawad, et al.
Nutrients|October 14, 2023
Standard Patient History Can Be Augmented Using Ethnographic Foodlife QuestionsJune Jo Lee, John Wesley McWhorter, Gabrielle Bryant, et al.
International Journal of Cancer|March 5, 2004
Protection against MUC1 expressing mouse tumours by intra-muscular injection of MUC1 cDNA requires functional CD8+ and CD4+ T cells but does not require the MUC1 tandem repeat domainTim Plunkett, Rosalind Graham, Isobel Correa, et al.
Transfusion|January 11, 2012
How do we monitor hospital transfusion practice using an end-to-end electronic transfusion management system?Michael F Murphy, Edward Fraser, David Miles, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2019
HER2-Overexpressing/Amplified Breast Cancer as a Testing Ground for Antibody-Drug Conjugate Drug Development in Solid TumorsMark D Pegram, David Miles, C Kimberly Tsui, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2012
Combining capecitabine and bevacizumab in metastatic breast cancer: a comprehensive reviewDavid Miles, Christoph Zielinski, Miguel Martin, et al.
European Journal of Cancer (Oxford, England : 1990)|November 28, 2017
Overall survival in MERiDiAN, a double-blind placebo-controlled randomised phase III trial evaluating first-line bevacizumab plus paclitaxel for HER2-negative metastatic breast cancerDavid Miles, David Cameron, Magalie Hilton, et al.
Physical Review. E|June 17, 2023
Self-diffusion of a relativistic Lennard-Jones gas via semirelativistic molecular dynamicsDavid Miles Testa, Pontus Svensson, Jacob Jackson, et al.
Biomolecules|September 28, 2024
Advancements in Green Nanoparticle Technology: Focusing on the Treatment of Clinical PhytopathogensSunny Mukherjee, Anamika Verma, Lingxue Kong, et al.
Functional & Integrative Genomics|February 23, 2013
Transcriptional profiling of Zea mays roots reveals roles for jasmonic acid and terpenoids in resistance against Phytophthora cinnamomiJane Alisa Allardyce, James Edward Rookes, Hashmath Inayath Hussain, et al.
Targeted Oncology|January 23, 2017
Splenic Enlargement and Bone Marrow Hyperplasia in Patients Receiving Trastuzumab-Emtansine for Metastatic Breast CancerMichael Kosmin, Andreas Makris, Noorulhuda Jawad, et al.
Nutrients|October 14, 2023
Standard Patient History Can Be Augmented Using Ethnographic Foodlife QuestionsJune Jo Lee, John Wesley McWhorter, Gabrielle Bryant, et al.
International Journal of Cancer|March 5, 2004
Protection against MUC1 expressing mouse tumours by intra-muscular injection of MUC1 cDNA requires functional CD8+ and CD4+ T cells but does not require the MUC1 tandem repeat domainTim Plunkett, Rosalind Graham, Isobel Correa, et al.
Transfusion|January 11, 2012
How do we monitor hospital transfusion practice using an end-to-end electronic transfusion management system?Michael F Murphy, Edward Fraser, David Miles, et al.
Pageof 6